GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

GlobeStar Therapeutics GSTC · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

GlobeStar Therapeutics — daily GSTC Delayed
Market value
$116,292
Last close × shares
Volume
300k
Shares, 30 Oct 2026

About GlobeStar Therapeutics

Its shares trade under the ticker GSTC. It has been listed since 21 May 2011. In the fiscal year to 30 September 2020, it reported revenue of $100 and a net loss of $541,700. At that date it held total assets of $89,900 and shareholders' equity of −$659,200.

GlobeStar Therapeutics Corp. is a clinical stage biotechnology company, which engages in the manufacture and patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company is headquartered in Richland, Washington. The company went IPO on 2011-05-21. The firm is focused on introducing a patented formulation of drugs for the treatment of Multiple Sclerosis and other neurodegenerative diseases. The firm owns the global license from the inventors, who are based in Italy. The firm has acquired a license for a patented method of treating neurodegenerative diseases such as Multiple Sclerosis by administering a synergistically effective amount of the composition to an individual suffering from neurodegeneration and treating neurodegeneration. GlobeStar Therapeutics is initiating discussions with the Food and Drug Administration (FDA) on clinical trial design in preparation for FDA submission and approval pathway.

Figures and description from our data supplier, not checked against the company's own report.

More about GlobeStar Therapeutics →

Latest on GlobeStar Therapeutics

Our reporting

We have not reported on GlobeStar Therapeutics yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is GlobeStar Therapeutics's ticker?

GlobeStar Therapeutics trades as GSTC on its US listing, under ISIN US37960P1049.

What was GlobeStar Therapeutics's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.